AllianceBernstein’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-168,281
Closed -$3.51M 3374
2022
Q3
$3.51M Sell
168,281
-2,302
-1% -$47.9K ﹤0.01% 1558
2022
Q2
$3.54M Buy
170,583
+3,920
+2% +$69.8K ﹤0.01% 1619
2022
Q1
$2.8M Buy
166,663
+547
+0.3% +$9.56K ﹤0.01% 1897
2021
Q4
$3.32M Buy
166,116
+209
+0.1% +$3.94K ﹤0.01% 1840
2021
Q3
$3.01M Sell
165,907
-6,438
-4% -$148K ﹤0.01% 1915
2021
Q2
$4.65M Buy
172,345
+8,680
+5% +$243K ﹤0.01% 1668
2021
Q1
$4.91M Buy
163,665
+1,410
+0.9% +$48.1K ﹤0.01% 1574
2020
Q4
$4.66M Buy
162,255
+7,600
+5% +$205K ﹤0.01% 1519
2020
Q3
$3.77M Buy
154,655
+300
+0.2% +$6.47K ﹤0.01% 1494
2020
Q2
$2.76M Buy
154,355
+63,518
+70% +$835K ﹤0.01% 1664
2020
Q1
$739K Sell
90,837
-200
-0.2% -$2.29K ﹤0.01% 2176
2019
Q4
$1.2M Sell
91,037
-70,924
-44% -$859K ﹤0.01% 2204
2019
Q3
$1.93M Sell
161,961
-11,085
-6% -$205K ﹤0.01% 1944
2019
Q2
$4.23M Buy
173,046
+7,015
+4% +$202K ﹤0.01% 1531
2019
Q1
$5.29M Buy
+166,031
New +$5.89M ﹤0.01% 1351

Other funds holding CVET

AllianceBernstein's CVET Position: Q4 2022 in Review

AllianceBernstein sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 168,281 shares — an estimated $3.51M sold.

AllianceBernstein first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $5.29M in Q1 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • AllianceBernstein reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • AllianceBernstein sold 168,281 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $3.51M.
  • AllianceBernstein first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • AllianceBernstein's Covetrus, Inc. Common Stock position peaked at $5.29M in Q1 2019.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on AllianceBernstein's 13F filing for Q4 2022, filed 15 Feb 2023.